Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.

Berthebaud M, Rivière C, Jarrier P, Foudi A, Zhang Y, Compagno D, Galy A, Vainchenker W, Louache F. RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood. 2005 Nov 01; 106(9):2962-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.